Ex Parte LINSLEY et al - Page 10




              Appeal No. 1999-2330                                                                                      
              Application No. 08/219,200                                                                                

                     Finally, the examiner finds that Yi-qun indicates that ?it is clear that inhibition of T           
              cell response to soluble antigens will require the blocking of both B7-2 and B7-1 to be                   
              effective.  More important it is unlikely that ongoing T cell response will be susceptible                
              to inhibition by anti-B7 reagents, for example in autoimmune disease.”  Id.                               
                     For their part, appellants first argue that, ?one is not required to enable any more               
              than what is claimed.”   Brief, page 7.1   Appellants further argue that Lenschow, of                     
              record, provides ?in vivo data which show that blocking the CD28 receptor from binding                    
              the B7 antigen using only CD28 results in manipulation of the immune system.                              
              Lenschow conclude that blocking the interaction of co-stimulatory molecules such as                       
              CD28-B7 may provide a new approach to immunosuppression.”  Brief, page 9.                                 
              Appellants argue that, on the basis of this publication, a 35 U.S.C.  § 101 rejection was                 
              withdrawn by the examiner, however, the lack of enablement rejection was improperly                       
              maintained in view of Lenschow.  Brief, pages 11-12.                                                      



                     1 We note, the "invention" referred to in the enablement requirement of section                    
              112 is the claimed invention.  Lindemann Maschinenfabrik GMBH v. American Hoist                           
              and  Derrick Co., 730 F.2d 1452, 1463, 221 USPQ 481, 489 (Fed. Cir. 1984) (the                            
              "question is whether the disclosure is sufficient to enable those skilled in the art to                   
              practice the claimed invention"); Raytheon Co. v. Roper Corp. , 724 F.2d 951, 956, 220                    
              USPQ 592, 596 (Fed. Cir. 1983).  That claims are interpreted in light of the specification                
              does not mean that everything expressed in the specification must be read into all the                    
              claims.  On the contrary, as was said in Environmental Designs, Ltd. v. Union Oil Co. of                  
              California, 713 F.2d 693, 699, 218 USPQ 865, 870-71 (Fed. Cir. 1983): The                                 
              specification must be sufficiently explicit and complete to enable one skilled in the art to              
              practice the invention, while a claim defines only that which the patentee regards as his                 
              invention.  35 U.S.C. §112.  The claim, not the specification, measures the invention.                    
                                                          10                                                            





Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007